Maravai LifeSciences Holdings (MRVI) Earnings Analysis
Maravai LifeSciences Holdings (MRVI) next reports earnings on 2026-08-10, consensus EPS -0.05 USD. Last quarter (2026-05-07) it beat with EPS 0.01 USD vs -0.05 USD est (+120%). It has beaten estimates in 2/7 recent quarters (29%). Trailing P/E -9.79.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MRVI next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | -0.05 USD |
| Revenue estimate | 0.05B |
MRVI earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | 0.01 USD | -0.05 USD | +120% | Beat |
| 2026-02-25 | -0.04 USD | -0.07 USD | +42.9% | Beat |
| 2025-11-06 | -0.08 USD | -0.06 USD | -33.3% | Miss |
| 2025-08-11 | -0.08 USD | -0.06 USD | -33.3% | Miss |
| 2025-05-12 | -0.08 USD | -0.07 USD | -14.3% | Miss |
| 2025-03-18 | -0.06 USD | -0.03 USD | -100% | Miss |
| 2024-11-07 | -0.02 USD | -0.008 USD | -150% | Miss |
Beat rate: 2/7 (29%) over reported quarters with consensus data.
MRVI valuation and analyst view
| Trailing P/E | -9.79 |
|---|---|
| Trailing EPS | -0.71409 USD |
| Price / book | 4.91 |
| Dividend yield | 0.00% |
| Market cap | 1.95B |
| Analyst consensus | Buy (7 buy / 6 hold / 1 sell) |
| Avg price target | 6 USD |
Related research pages
Frequently asked questions
When is Maravai LifeSciences Holdings (MRVI)'s next earnings date?
Maravai LifeSciences Holdings is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.05 USD and revenue estimate of 0.05B.
Did MRVI beat earnings last quarter?
In its 2026-05-07 report, MRVI posted EPS of 0.01 USD versus a -0.05 USD estimate — a beat of 120%.
What is MRVI's earnings track record?
Over the last 7 reported quarters with consensus data, MRVI beat estimates 2 times (29%).
What is MRVI's current P/E ratio and EPS?
MRVI trades at a trailing P/E of -9.79 on trailing EPS of -0.7140876620272356 USD.
What do analysts rate MRVI?
Analyst consensus is "Buy" across 14 ratings (0 strong buy, 7 buy, 6 hold, 1 sell, 0 strong sell). Average 12-month price target: 6 USD.